Clifford Chance has represented Unilever on its $2.71 billion purchase of Carver Korea, a maker of facial masks and skincare products, from its founder, Goldman Sachs, and Bain Capital, which tapped Ropes & Gray for advice.

Two Korean firms were also involved in the deal, serving as local counsel: Bae, Kim & Lee acted for Unilever while Kim & Chang advised Bain Capital and Goldman Sachs.

According to Reuters, the acquisition gives Unilever what it said is the fastest-growing skincare business in South Korea through its AHC brand of anti-ageing creams, moisturisers and other related products. The global conglomerate also gains a strong foothold in North Asia, the world’s largest skincare market, via Carver.

The deal comes amid political tensions between China and South Korea, which have dented earnings of many South Korean beauty businesses, reported Reuters. Chinese tourists have been big buyers of South Korean cosmetics, but China this year banned group tours to the country over Seoul’s decision to deploy an anti-missile system to counter North Korean threats.

The Ropes team was led by Seoul partner Jaewoo Lee and Boston partner William Mone.

Related Articles

CC, Paul Hastings lead on CR Beverages’ HK IPO

by Charlie Wu 吴卓言 |

Clifford Chance and Jingtian & Gongcheng are advising China Resources Beverages, the beverage division of the state-owned China Resources Enterprise, on its upcoming Hong Kong IPO, which is expected to raise up to $1 billion. Paul Hastings and Zhong Lun Law Firm are acting for the joint sponsors.

Haiwen, CC advise on China TCM's $2 bln take-private deal

Sinopharm Group, an investment consortium led by Sinopharm Group, and China Traditional Chinese Medicine Holdings (China TCM) recently announced a take-private deal for the Hong Kong-listed China TCM through a scheme of arrangement.

CC, Davis Polk act on ChaPanda’s $330 mln Hong Kong IPO

by Charlie Wu 吴卓言 |

Davis Polk & Wardwell and Jingtian & Gongcheng have advised Sichuan Baicha Baidao, a Chinese low-priced tea chain also known as ChaPanda, on its $330 million IPO on the Hong Kong Stock Exchange, with Clifford Chance and King & Wood Mallesons acting for the sponsor CICC and underwriters.